Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Depreciation & Amortization (CF) (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Depreciation & Amortization (CF) for 4 consecutive years, with $6841.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) changed 0.01% to $6841.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27361.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $27361.0 for FY2025, 0.0% changed from the prior year.
  • Depreciation & Amortization (CF) hit $6841.0 in Q4 2025 for Coya Therapeutics, roughly flat from $6840.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $12455.0 in Q3 2022 to a low of $4033.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $6840.2 across 4 years, with a median of $6840.0 in 2022.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 69.6% in 2023; the steepest drop was 45.07% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then grew by 0.01% to $6841.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for COYA at $6841.0 in Q4 2025, $6840.0 in Q3 2025, and $6840.0 in Q2 2025.